Skip to content
ReportWire

Breaking News & Top Current Stories – Latest US News and News from Around the World

Tag: Dana-Farber Cancer Institute;ESMO 2023;neuroendocrine cancer;Cabozantinib ;clinical trial;Cancer

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds

October 22, 2023October 22, 2023 · Breaking News

Newswise — Boston – A drug that simultaneously strikes cancer cells’ growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with…

Read more Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds
© 2026 . All rights reserved.